Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out
Applied DNA Sciences (NASDAQ:APDN) announced it will release its fourth quarter and fiscal year 2024 financial results after market close on December 17, 2024. The company will host a conference call and webcast for investors on January 9, 2025, at 4:30 p.m. ET, which will include an update on its GMP manufacturing facility build-out. The presentation will be accessible via webcast and conference call, with replay options available for 7 days following the event. An accompanying slide presentation will be available on the company's investor relations website.
Applied DNA Sciences (NASDAQ:APDN) ha annunciato che rilascerà i suoi risultati finanziari del quarto trimestre e dell'anno fiscale 2024 dopo la chiusura del mercato il 17 dicembre 2024. L'azienda organizzerà una conferenza telefonica e una trasmissione web per gli investitori il 9 gennaio 2025, alle 16:30 ET, che includerà un aggiornamento sulla costruzione del suo impianto di produzione GMP. La presentazione sarà accessibile tramite webcast e conferenza telefonica, con opzioni di replica disponibili per 7 giorni dopo l'evento. Un accompagnamento di diapositive sarà disponibile sul sito web delle relazioni con gli investitori della società.
Applied DNA Sciences (NASDAQ:APDN) anunció que publicará sus resultados financieros del cuarto trimestre y del año fiscal 2024 después del cierre del mercado el 17 de diciembre de 2024. La compañía llevará a cabo una llamada de conferencia y una transmisión por web para inversores el 9 de enero de 2025, a las 4:30 p.m. ET, que incluirá una actualización sobre la construcción de su instalación de fabricación GMP. La presentación estará disponible a través de la transmisión web y la llamada de conferencia, con opciones de repetición disponibles durante 7 días después del evento. Una presentación de diapositivas acompañante estará disponible en el sitio web de relaciones con los inversores de la empresa.
Applied DNA Sciences (NASDAQ:APDN)은 2024년 12월 17일 시장 종료 후 2024년 4분기 및 회계 연도 재무 결과를 발표할 것이라고 발표했습니다. 이 회사는 2025년 1월 9일 오후 4:30 ET에 투자자를 위한 컨퍼런스 콜과 웹캐스트를 진행할 예정이며, 여기에는 GMP 제조 시설 건설에 대한 업데이트가 포함될 것입니다. 발표는 웹캐스트와 전화 회의를 통해 접근할 수 있으며, 이벤트 후 7일 동안 다시 들을 수 있는 옵션이 제공됩니다. 동반된 슬라이드 프레젠테이션은 회사의 투자자 관계 웹사이트에서 확인할 수 있습니다.
Applied DNA Sciences (NASDAQ:APDN) a annoncé qu'elle publiera ses résultats financiers du quatrième trimestre et de l'exercice fiscal 2024 après la fermeture des marchés le 17 décembre 2024. L'entreprise organisera une conférence téléphonique et un webinaire pour les investisseurs le 9 janvier 2025, à 16h30 ET, qui inclura une mise à jour sur la construction de ses installations de fabrication GMP. La présentation sera accessible par webinaire et conférence téléphonique, avec des options de rediffusion disponibles pendant 7 jours après l'événement. Une présentation de diapositives accompagnante sera disponible sur le site des relations investisseurs de l'entreprise.
Applied DNA Sciences (NASDAQ:APDN) gab bekannt, dass die Finanzergebnisse für das vierte Quartal und das Geschäftsjahr 2024 nach Marktschluss am 17. Dezember 2024 veröffentlicht werden. Das Unternehmen wird am 9. Januar 2025 um 16:30 Uhr ET eine Telefonkonferenz und ein Webcast für Investoren veranstalten, die ein Update über den Bau seines GMP-Fertigungsstandorts enthalten werden. Die Präsentation wird über Webcast und Telefonkonferenz zugänglich sein, mit Wiederholungsoptionen, die für 7 Tage nach der Veranstaltung verfügbar sind. Eine begleitende Folienpräsentation wird auf der Website der Investor Relations des Unternehmens verfügbar sein.
- GMP manufacturing facility expansion indicates business growth investment
- Delayed earnings discussion - 23 days gap between results release and conference call
STONY BROOK, NY / ACCESSWIRE / December 16, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in polymerase chain reaction (PCR)-based technologies, today announced that it will release its fourth quarter and fiscal year 2024 financial results after the market close on Tuesday, December 17, 2024.
The Company will host a conference call for the investment community to coincide with an update on its GMP manufacturing facility build-out on Thursday, January 9, 2025, at 4:30 p.m. ET.
Webcast and Conference Call Date & Time: Thursday, January 9 @ 4:30 p.m. ET
Dial In:
Domestic callers (toll free): 844-887-9402
International callers: 412-317-6798
Canadian callers (toll free): 866-605-3852
Live webcast: https://event.choruscall.com/mediaframe/webcast.html?webcastid=3UkskFxG
A replay of the conference call will be available for 7 days following the conclusion of the call:
Replay for domestic callers (toll free): 877-344-7529, replay access code 7896562
Replay for international callers: 412-317-0088, replay access code 7896562
Replay for Canadian callers (toll free): 855-669-9658, replace access code 7896562
An accompanying slide presentation will be embedded in the webcast (live and replay) and can be accessed under the ‘Company Events' section of the Applied DNA investor relations website at https://investors.adnas.com/news-events/company-events/. The webcast replay of the call will be available at the same site approximately one hour after the end of the call.
About Applied DNA Sciences
Applied DNA Sciences is a biotechnology company developing technologies to produce and detect deoxyribonucleic acid ("DNA"). Using the polymerase chain reaction ("PCR") to enable both the production and detection of DNA, we operate in three primary business markets: (i) the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNA polymerase ("RNAP") for use in the production of mRNA therapeutics; and, (ii) the detection of DNA and RNA in molecular diagnostics and genetic testing services; and (iii) the manufacture and detection of DNA for industrial supply chain security services.
Visit adnas.com for more information. Follow us on X and LinkedIn. Join our mailing list.
For additional information:
Investor Relations: Sanjay M. Hurry, 917-733-5573, sanjay.hurry@adnas.com
Web: https://investors.adnas.com/
SOURCE: Applied DNA Sciences, Inc.
View the original press release on accesswire.com
FAQ
When will Applied DNA (APDN) release Q4 and FY2024 earnings?
When is Applied DNA's (APDN) earnings conference call for Q4 2024?
What will Applied DNA (APDN) discuss in their January 9, 2025 conference call?
How long will Applied DNA's (APDN) Q4 2024 earnings call replay be available?
